- Home
- TRVI vs APEI Comparison
TRVI vs APEI Comparison
Compare TRVI & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- APEI
- Stock Information
- Founded
- TRVI 2011
- APEI 1991
- Country
- TRVI United States
- APEI United States
- Employees
- TRVI N/A
- APEI N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- APEI Other Consumer Services
- Sector
- TRVI Health Care
- APEI Consumer Discretionary
- Exchange
- TRVI Nasdaq
- APEI Nasdaq
- Market Cap
- TRVI 363.7M
- APEI 396.4M
- IPO Year
- TRVI 2019
- APEI 2007
- Fundamental
- Price
- TRVI $4.60
- APEI $21.26
- Analyst Decision
- TRVI Strong Buy
- APEI Buy
- Analyst Count
- TRVI 8
- APEI 4
- Target Price
- TRVI $9.31
- APEI $21.00
- AVG Volume (30 Days)
- TRVI 739.7K
- APEI 88.0K
- Earning Date
- TRVI 03-19-2025
- APEI 03-06-2025
- Dividend Yield
- TRVI N/A
- APEI N/A
- EPS Growth
- TRVI N/A
- APEI N/A
- EPS
- TRVI N/A
- APEI 0.56
- Revenue
- TRVI N/A
- APEI $613,253,000.00
- Revenue This Year
- TRVI N/A
- APEI $5.70
- Revenue Next Year
- TRVI N/A
- APEI $4.20
- P/E Ratio
- TRVI N/A
- APEI $38.15
- Revenue Growth
- TRVI N/A
- APEI 2.18
- 52 Week Low
- TRVI $2.30
- APEI $10.30
- 52 Week High
- TRVI $5.05
- APEI $23.84
- Technical
- Relative Strength Index (RSI)
- TRVI 62.80
- APEI 44.89
- Support Level
- TRVI $3.93
- APEI $20.78
- Resistance Level
- TRVI $4.14
- APEI $22.40
- Average True Range (ATR)
- TRVI 0.29
- APEI 0.81
- MACD
- TRVI 0.06
- APEI -0.07
- Stochastic Oscillator
- TRVI 64.82
- APEI 21.62
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About APEI American Public Education Inc.
American Public Education Inc provides online and on-campus postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.